|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antipsychotics and hyperprolactinaemia: clinical recommendations 显示文摘 | Peveler RC Branford D Citrome L | 2008 | J Psychopharmacol2008，22，2： | 1 |
| 2 | Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998显示文摘 | Levine J Allingham B | 2000 | Psychiatr Serv2000，51，： | 1 |
| 3 | Lamotrigine as add on therapy in schizuphrenia: results of 2 placebo-controlled trials 显示文摘 | Goff DC Keefe R Citrome L | 2007 | J Clin Psychophannaco12007，27，6： | 1 |
| 4 | Therapeutic improvements expected in the near future fbr sehizophrenia and schizoaltctive disorder: an appraisal of phase m clinical trials of schizophrenia- targeted therapies as found in US and EU clinical trial registries显示文摘 | GARAY RP CITROME L SAMALIN L et (d | 2016 | Expert Opin Pharmacother2016，17，7： | 1 |
| 5 | Ziprasidone for schizophrenia and bipolar disorder:a review of the clinical trials显示文摘 | Greenberg WM Citrome L | 2007 | CNS Drug Rev2007，13，2： | 1 |
| 6 | Ziprasidone for schizophrenia and bipolar disorder:a review of the clinical trials显示文摘 | Greenberg WM Citrome L | 2007 | CNS Drug Rev2007，13，2： | 1 |
| 7 | A study of the safety,efficacy,and tolerability of switching from the standard delayed release preparation of divalproex sodium to the extended release formulation in patients with schizophrenia显示文摘 | Citrome L Tremeau F Wynn PS | 2004 | J Clin Psychopharmacol2004，24，： | 1 |
| 8 | Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study显示文摘 | Volavka J Czobor P Citrome L | 2012 | CNS spectrums2012，10，7： | 1 |
| 9 | A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsyehotics : an evidence-based medicine approach显示文摘 | CITROME L | 2013 | CNS Drugs2013，27，11： | 1 |
| 10 | Liraglutide subcutaneous injection for weight loss:where does it fit显示文摘 | Pahlajani S Citrome L | 2015 | International journal of clinical practice2015，69，7： | 1 |
| 11 | Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion 显示文摘 | Citrome L | 2010 | Expert Opin Drug Metab Toxicol2010，6，12： | 1 |
| 12 | 'Meta-guidelines' for the management of patients with schizophrenia 显示文摘 | STAHL S M MORRISSETI'E D A CITROME L | 2013 | CNS Spectr2013，18，3： | 1 |
| 13 | Efficacy of iloperidone in schizophrenia: A PANSS five-factor analysis显示文摘 | CITROME L MENG X HOCHFELD M | 2011 | Schizophr Res2011，131，13： | 1 |
| 14 | Managing treatment re-sistant schizophrenia evidence from randomized clinicaltrials显示文摘 | Citrome L Bilder RM Volavka J | 2002 | J Psychiatr Pratt2002，8，3： | 1 |
| 15 | Cariprazine in schizophrenia: clinical efficacy tolerability, and place in therapy显示文摘 | CITROME L | 2013 | Adv Ther2013，30，2： | 1 |
| 16 | Efllcacy of iloperidone in the short-term treatment of schizophrenia: a posthoc analysis of pooled patient data from four phase Ill , placebo and active controlled trials显示文摘 | CITROME L MENG X HOCHFELD M | 2012 | Hum Psychopharmacol2012，，： | 1 |
| 17 | Cariprazine in bipolar disorder: clinical efficacy tolerabiity, and place in therapy显示文摘 | CITROME L | 2013 | Adv Ther2013，30，2： | 1 |
| 18 | Cariprazine: chemistry, pharmaeodynamics pharmaeokinetics, and metabolism, clinical efficacy, safety and tolerability显示文摘 | CITROME L | 2013 | Expert Opin Drug Metah Toxieol2013，9，2： | 1 |
| 19 | Paliperidone: quo vadis? 显示文摘 | CITROME L | 2007 | lnt J Clin Pract2007，61，4： | 1 |
| 20 | Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone 显示文摘 | CITROME L CASEY D E DANIEL D G | 2004 | Psychiatr Serv2004，55，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员